Specialty drug price caps drastically reduce out-of-pocket costs without increasing health plan spending

(By Katie Adams for Becker’s Hospital Review)

States that implemented out-of-pocket price caps for expensive specialty drugs saw patient spending on these medications decrease $351 per month, according to new analysis published in the New England Journal of Medicine.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org